NO165400C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive cefemforbindelser. - Google Patents
Analogifremgangsmaate ved fremstilling av terapeutisk aktive cefemforbindelser.Info
- Publication number
- NO165400C NO165400C NO850010A NO850010A NO165400C NO 165400 C NO165400 C NO 165400C NO 850010 A NO850010 A NO 850010A NO 850010 A NO850010 A NO 850010A NO 165400 C NO165400 C NO 165400C
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- therapeutic active
- analogy procedure
- cefem compounds
- cefem
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
- C07D501/34—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/305—Saturated compounds containing more than one carboxyl group containing ether groups, groups, groups, or groups
- C07C59/315—Saturated compounds containing more than one carboxyl group containing ether groups, groups, groups, or groups containing halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB848400024A GB8400024D0 (en) | 1984-01-03 | 1984-01-03 | Cephalosporin antibiotics |
Publications (3)
Publication Number | Publication Date |
---|---|
NO850010L NO850010L (no) | 1985-07-04 |
NO165400B NO165400B (no) | 1990-10-29 |
NO165400C true NO165400C (no) | 1991-02-06 |
Family
ID=10554497
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO850010A NO165400C (no) | 1984-01-03 | 1985-01-02 | Analogifremgangsmaate ved fremstilling av terapeutisk aktive cefemforbindelser. |
Country Status (28)
Country | Link |
---|---|
US (1) | US4602012A (sv) |
JP (1) | JPH0791305B2 (sv) |
KR (1) | KR920001770B1 (sv) |
AT (1) | AT392279B (sv) |
AU (1) | AU578441B2 (sv) |
BE (1) | BE901436A (sv) |
CA (1) | CA1265512A (sv) |
CH (1) | CH666274A5 (sv) |
DE (1) | DE3500090A1 (sv) |
DK (1) | DK1585A (sv) |
ES (2) | ES8703884A1 (sv) |
FI (1) | FI83082C (sv) |
FR (1) | FR2557571B1 (sv) |
GB (2) | GB8400024D0 (sv) |
GR (1) | GR850007B (sv) |
HK (1) | HK105890A (sv) |
HU (1) | HU193076B (sv) |
IL (1) | IL73989A (sv) |
IT (1) | IT1178349B (sv) |
LU (1) | LU85719A1 (sv) |
NL (1) | NL8403974A (sv) |
NO (1) | NO165400C (sv) |
NZ (1) | NZ210725A (sv) |
PH (1) | PH22630A (sv) |
PT (1) | PT79787B (sv) |
SE (2) | SE8500011L (sv) |
SG (1) | SG81390G (sv) |
ZA (1) | ZA8545B (sv) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8320521D0 (en) * | 1983-07-29 | 1983-09-01 | Glaxo Group Ltd | Chemical process |
GB8524001D0 (en) * | 1985-09-30 | 1985-11-06 | Glaxo Group Ltd | Pharmaceutical composition |
DE3804841A1 (de) * | 1988-02-17 | 1989-08-31 | Hoechst Ag | Cephalosporinderivate und verfahren zu ihrer herstellung |
GB8810396D0 (en) * | 1988-05-03 | 1988-06-08 | Glaxo Group Ltd | Chemical process |
GB8810395D0 (en) * | 1988-05-03 | 1988-06-08 | Glaxo Group Ltd | Chemical process |
GB8810393D0 (en) * | 1988-05-03 | 1988-06-08 | Glaxo Group Ltd | Chemical process |
GB8810392D0 (en) * | 1988-05-03 | 1988-06-08 | Glaxo Group Ltd | Chemical process |
GB8810394D0 (en) * | 1988-05-03 | 1988-06-08 | Glaxo Group Ltd | Chemical process |
US5063224A (en) * | 1990-07-09 | 1991-11-05 | Eli Lilly And Company | R-cefuroxime axetil |
EP0504107B1 (de) * | 1991-03-11 | 1994-12-07 | Säurefabrik Schweizerhall | Verfahren zur Herstellung von chlorierten Carbonsäureestern |
EP0508943B1 (de) * | 1991-03-11 | 1994-12-14 | Säurefabrik Schweizerhall | Verfahren zur Herstellung von halogenierten Carbonsäureestern |
GB9405856D0 (en) * | 1994-03-24 | 1994-05-11 | Smithkline Beecham Plc | Pharmaceutical formulation |
JP2001131071A (ja) * | 1999-10-29 | 2001-05-15 | Meiji Seika Kaisha Ltd | 非晶質および非晶質を含有する医薬組成物 |
PT1342470E (pt) * | 2002-03-04 | 2007-11-13 | Orbus Pharma Inc | ''composições de cefuroxima axetil de libertação rápida'' |
WO2008155615A2 (en) * | 2007-06-18 | 2008-12-24 | Orchid Chemicals & Pharmaceuticals Limited | An improved process for the preparation of cephalosporin antibiotic |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1453049A (en) * | 1973-08-21 | 1976-10-20 | Glaxo Lab Ltd | Cephalosporing antibiotics |
GB1426717A (en) * | 1972-03-13 | 1976-03-03 | Astra Laekemedel Ab | Penicillins |
GB1425933A (en) * | 1972-03-13 | 1976-02-25 | Astra Laekemedel Ab | Cephalosporins |
CA1093549A (en) * | 1976-02-16 | 1981-01-13 | Michael Gregson | Cephalosporin antibiotics |
GB1571683A (en) * | 1976-02-16 | 1980-07-16 | Glaxo Operations Ltd | Ester derivatives of cefuroxime |
GB1572993A (en) * | 1976-02-16 | 1980-08-13 | Glaxo Operations Ltd | Ester derivatives of cefuroxime |
CA1094545A (en) * | 1976-02-16 | 1981-01-27 | Michael Gregson | Cephalosporin antibiotics |
GB1598568A (en) * | 1977-04-19 | 1981-09-23 | Glaxo Lab Ltd | Esters of(6r,7r)-3-carbamoyloxymethyl-7-((z)-2-(fur-2-yl)-2-methoxyiminoacetamido)-ceph-3-em-4-carboxylic acid |
FR2476087A1 (fr) * | 1980-02-18 | 1981-08-21 | Roussel Uclaf | Nouvelles oximes derivees de l'acide 3-alkyloxy ou 3-alkyl-thiomethyl 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments |
IT1210868B (it) * | 1982-04-01 | 1989-09-29 | Opos Biochimica Srl | Derivati della cefuroxima attivi per via orale procedimenti per laloro preparazione e relative composizioni farmaceutuche. |
YU44680B (en) * | 1982-07-30 | 1990-12-31 | Glaxo Lab Ltd | Process for obtaining very pure amorphous form of cephuroxim axetile |
GB8320520D0 (en) * | 1983-07-29 | 1983-09-01 | Glaxo Group Ltd | Chemical process |
GB8320521D0 (en) * | 1983-07-29 | 1983-09-01 | Glaxo Group Ltd | Chemical process |
-
1984
- 1984-01-03 GB GB848400024A patent/GB8400024D0/en active Pending
- 1984-12-21 AU AU37046/84A patent/AU578441B2/en not_active Ceased
- 1984-12-21 NZ NZ210725A patent/NZ210725A/en unknown
- 1984-12-28 JP JP59282144A patent/JPH0791305B2/ja not_active Expired - Lifetime
- 1984-12-31 KR KR1019840008585A patent/KR920001770B1/ko not_active IP Right Cessation
- 1984-12-31 NL NL8403974A patent/NL8403974A/nl not_active Application Discontinuation
- 1984-12-31 IT IT8449383A patent/IT1178349B/it active
-
1985
- 1985-01-02 ES ES539311A patent/ES8703884A1/es not_active Expired
- 1985-01-02 NO NO850010A patent/NO165400C/no unknown
- 1985-01-02 PH PH31677A patent/PH22630A/en unknown
- 1985-01-02 DK DK1585A patent/DK1585A/da not_active Application Discontinuation
- 1985-01-02 SE SE8500011D patent/SE8500011L/sv not_active Application Discontinuation
- 1985-01-02 LU LU85719A patent/LU85719A1/fr unknown
- 1985-01-02 PT PT79787A patent/PT79787B/pt unknown
- 1985-01-02 FI FI850012A patent/FI83082C/sv not_active IP Right Cessation
- 1985-01-02 HU HU857A patent/HU193076B/hu unknown
- 1985-01-02 IL IL73989A patent/IL73989A/xx unknown
- 1985-01-02 US US06/688,354 patent/US4602012A/en not_active Expired - Lifetime
- 1985-01-02 GR GR850007A patent/GR850007B/el unknown
- 1985-01-02 CA CA000471321A patent/CA1265512A/en not_active Expired - Fee Related
- 1985-01-02 SE SE8500011A patent/SE466451B/sv not_active IP Right Cessation
- 1985-01-03 BE BE0/214284A patent/BE901436A/fr not_active IP Right Cessation
- 1985-01-03 ZA ZA8545A patent/ZA8545B/xx unknown
- 1985-01-03 GB GB08500091A patent/GB2152504B/en not_active Expired
- 1985-01-03 CH CH20/85A patent/CH666274A5/de not_active IP Right Cessation
- 1985-01-03 FR FR8500043A patent/FR2557571B1/fr not_active Expired
- 1985-01-03 AT AT12/85A patent/AT392279B/de active
- 1985-01-03 DE DE19853500090 patent/DE3500090A1/de active Granted
-
1986
- 1986-03-01 ES ES552577A patent/ES8705891A1/es not_active Expired
-
1990
- 1990-10-05 SG SG813/90A patent/SG81390G/en unknown
- 1990-12-13 HK HK1058/90A patent/HK105890A/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO160521C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 13alfa- alkylgonaner. | |
NO158021C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktivt d-fenylalanyl-l-prolyl-l-argininaldehydsulfat. | |
NO159089C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive glutarimidderivater. | |
NO161065C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-azetidinoner. | |
NO871267D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tiazepinforbindelser. | |
NO162238C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydro-4-oksonaftyridinderivater. | |
NO164097C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-(n-substituert-guanidino)-4-hetero-aryl-tiazol-derivater. | |
NO166320C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive tetrazolderivater. | |
NO864879L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tiazolforbindelser. | |
NO162858C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive thiazolidinderivater. | |
NO166083C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyridazodiazepinderivater. | |
NO164168C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,7,4-triazolforbindelser. | |
NO167912C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive aromatiske forbindelser | |
NO165400C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive cefemforbindelser. | |
NO166326C (no) | Fremgangsmaate ved fremstilling av terapeutisk aktive 3,7-substituerte-8-oxo-5-thia-1-azabicyclo-(4,2,0)oct-2-en-2-carboxylater. | |
NO159528C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive aminoguanidinderivater. | |
NO165842C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-forbindelser. | |
NO164897C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive oxazolidinonderivater. | |
NO167570C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive flavonforbindelser. | |
NO157538C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzothiazolsufonamidderivater. | |
NO161313C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive fluorallylaminderivater. | |
NO164020C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenetanolaminderivater. | |
NO161177C (no) | Analogifremgangsm te til fremstilling av terapeutisk aktive tioetere. | |
NO160000C (no) | Analogifremgangsm te for fremstilling av terapeutisk aktive forbindelser. | |
NO163330C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive isokinolinderivater. |